share_log

Cerebain Biotech Corp | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

SEC ·  Mar 13, 2012 02:51
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.